| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/30/1992 | DE4024347A1 Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentadiene derivatives, processes for their preparation and their pharmaceutical use |
| 01/30/1992 | DE4024345A1 Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentene derivatives, processes for their preparation and their pharmaceutical use |
| 01/29/1992 | EP0468885A1 1-Diphenylmethylpiperazine derivatives, their preparation, their use as medicines |
| 01/29/1992 | EP0468884A1 Benzimidazole derivatives, their preparation and their application as medicaments |
| 01/29/1992 | EP0468789A2 (Quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 01/29/1992 | EP0468785A2 (Quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 01/29/1992 | EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 01/29/1992 | EP0468470A1 Benzimidazoles, medicaments containing them and process for their preparation |
| 01/29/1992 | EP0468411A2 A mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
| 01/29/1992 | EP0468401A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments |
| 01/29/1992 | EP0468372A2 Substituted azoles, process for their preparation and their use |
| 01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
| 01/29/1992 | EP0468281A1 Substituted phenylacetylenes, pharmaceuticals containing them and methods for the preparation of these compounds and pharmaceuticals |
| 01/29/1992 | EP0468258A1 Substituted pyrido-oxazines |
| 01/29/1992 | EP0468187A2 Cyclic amide derivatives |
| 01/29/1992 | EP0468042A1 HOMOLOGATED VITAMIN D 2? COMPOUNDS AND THE CORRESPONDING 1-g(a)-HYDROXYLATED DERIVATIVES. |
| 01/29/1992 | EP0467957A1 Mercapto-acylamino acids |
| 01/29/1992 | EP0467895A1 Dihydropyridine antiallergy agents |
| 01/29/1992 | EP0467888A1 Treatment and prevention of oral mucositis with growth factors |
| 01/29/1992 | EP0324815B1 New 9-substituted carbocycline derivatives, process for manufacturing them and their use as drugs |
| 01/29/1992 | CN1058216A Substituted thiazolyl and substituted pyridinyl derivatives |
| 01/29/1992 | CN1058215A Oxazolyl derivatives |
| 01/29/1992 | CN1015334B Preparation method for derivertives |
| 01/28/1992 | WO1992002495A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 01/28/1992 | WO1992002494A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 01/28/1992 | WO1992002240A2 Novel methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | US5084481 6,8-dimercaptooctanoic acid and salts for rheumatic diseases |
| 01/28/1992 | US5084479 Aminomethylcycloalkylacetic acids for nervous system disorders |
| 01/28/1992 | US5084450 Progestomimetic and antiesterogenic steroids for animals |
| 01/28/1992 | US5084449 Anti-bacterial compositions comprising a substituted bis-(4-aminophenyl)-sulfone and a dihydro-folic acid reductase |
| 01/28/1992 | US5084279 Bioactivated pearl |
| 01/28/1992 | US5084275 Processes of preparing α-amylase inhibiting subtances from wheat |
| 01/28/1992 | CA2088161A1 Cyclopentane derivatives, process for their production and their pharmaceutical use |
| 01/28/1992 | CA2088159A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 01/28/1992 | CA2082804A1 Methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | CA1294975C Substituted biphenyl derivatives |
| 01/27/1992 | CA2047880A1 Benzimidazole derivatives, their preparation and pharmacological applications |
| 01/27/1992 | CA2047879A1 1-diphenylmethylpiperazine derivatives, their preparation and pharmacological applications |
| 01/27/1992 | CA2043823A1 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/25/1992 | WO1992001684A1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
| 01/25/1992 | CA2087848A1 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions |
| 01/24/1992 | CA2047306A1 Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
| 01/23/1992 | WO1992000999A1 Fibroblast growth factor receptors |
| 01/23/1992 | WO1992000994A1 Growth-promoting agent |
| 01/23/1992 | WO1992000966A1 N-dimethoxy phenyl alkyl-n'-imidazolyl phenyl amidine derivatives and process thereof |
| 01/23/1992 | WO1992000960A1 Beta-alethine use in cell culture and therapy |
| 01/23/1992 | WO1992000956A1 Inhibitors of aspartic proteases |
| 01/23/1992 | WO1992000955A1 Vitaletheine and use in cell culture and therapy |
| 01/23/1992 | WO1992000727A1 Autobiotics and their use in eliminating nonself cells in vivo |
| 01/23/1992 | DE4123714A1 Recovering oligo:saccharide(s) from cereal plants |
| 01/23/1992 | DE4023215A1 New substd. azole derivs. angiotensin II antagonists - for treating hypertension, coronary insufficiency, myocardial infarct, coronary hypertrophy, arteriosclerosis etc. |
| 01/23/1992 | CA2086513A1 Autobiotics and their use in eliminating nonself cells in vivo |
| 01/22/1992 | EP0467660A2 Use of d-limonenes as testosterone-5-alpha-reductase inhibitor and as hair grower |
| 01/22/1992 | EP0467637A1 Pyrazolo(1,5-a)pyridine compounds, and production and use thereof |
| 01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/22/1992 | EP0467207A2 Purinderivate |
| 01/22/1992 | EP0466966A1 Synthetic chondroitin sulfate proteoglycan and process for producing the same |
| 01/22/1992 | EP0466854A1 T cell growth factor |
| 01/22/1992 | EP0466813A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins |
| 01/22/1992 | CN1058016A Benzoic acid derivatives for treating leukotriene-related diseases |
| 01/22/1992 | CN1058015A 苯甲酸衍生物 Benzoic acid derivatives |
| 01/22/1992 | CN1057961A Composition pharmaceutique injectable |
| 01/22/1992 | CA2047467A1 Substituted azoles, a process for their preparation, and their use |
| 01/22/1992 | CA2047327A1 Substituted pyrido-oxazine inhibitors of hmg-coa reductase |
| 01/21/1992 | US5082937 Benzodiazepines and applications in therapeutic practice |
| 01/21/1992 | US5082843 Pyrazinyl and pyridazinyl ethers |
| 01/21/1992 | US5082838 Antiinflammatory, immune diseases |
| 01/21/1992 | CA1294738C Chemical derivatives of ghl-cu |
| 01/21/1992 | CA1294736C Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues |
| 01/21/1992 | CA1294619C Oleic acid esters and pharmaceutical compositions |
| 01/21/1992 | CA1294609C Process for producing low molecular alkali metal huminates |
| 01/21/1992 | CA1294551C Sustained release fluoride composition |
| 01/20/1992 | WO1992001687A1 Novel oxazolyl derivatives |
| 01/20/1992 | WO1992001683A1 Benzodiazepine derivatives |
| 01/20/1992 | CA2090023A1 Benzodiazepine derivatives |
| 01/20/1992 | CA2086545A1 Oxazolyl derivatives |
| 01/20/1992 | CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
| 01/20/1992 | CA2047030A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties |
| 01/19/1992 | CA2046999A1 Pyrazolo[1,5-a]pyridine compounds, and production and use thereof |
| 01/19/1992 | CA2044806A1 Purine derivatives |
| 01/15/1992 | EP0466585A1 Novel piperidin, tetrahydropyridine and pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/1992 | EP0466452A2 Thioxo heterocycles and their pharmaceutical use |
| 01/15/1992 | EP0466037A2 Process for enhancing the resistance of aquatic animals to disease |
| 01/15/1992 | EP0465913A2 Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them |
| 01/15/1992 | EP0465802A1 Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465508A1 Dietary supplement for insulin-resistant diabetics |
| 01/15/1992 | EP0235162B1 Cdna and gene for human angiogenin (angiogenesis factor) and methods of expression |
| 01/15/1992 | CN1057839A Azabenzimidazoles in treatment of asthma, arthritis and related diseases |
| 01/15/1992 | CN1057834A Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases |
| 01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | US5081284 N-Oxomethyl-Substituted Peptide |
| 01/14/1992 | US5081282 Prostaglandins |
| 01/14/1992 | US5081271 Novel benzoic acid derivatives and process for preparing the same |
| 01/14/1992 | US5081253 Imidazo(4,5-c)pyridines as antiosteoporotic agents |
| 01/14/1992 | US5081152 Azulene derivatives as thromboxane a2 and prostaglandin endoperoxide receptor antagonist |
| 01/14/1992 | US5081148 Blocking agents of edrf effect or formation for the treatment of shock |
| 01/14/1992 | US5081135 Bactericides |
| 01/14/1992 | US5081128 2,3-dihydro-1h-isoindole derivatives and their application in therapy |
| 01/14/1992 | US5081126 Quinolyl- and isoquinolyl-methoxyphenyl-dithioacetyl derivatives useful as antiinflammatory agents |